Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has emerged as one of the most studied medications for weight management, with clinical trials showing an average weight loss of 9.3 to 12.4 kilograms (20-27 pounds) over one year at maximum doses. However, the amount of weight you lose depends on multiple factors including your starting weight, metabolic genetics, adherence to the medication, and lifestyle changes. PlexusDx provides compounded semaglutide injections starting at just $149 per month, helping you access this powerful tool without the uncertainty of generic outcomes.
Average Semaglutide Weight Loss Results from Clinical Evidence
The landmark STEP trials evaluated semaglutide's effectiveness across thousands of participants with obesity or overweight status. Patients receiving the highest maintenance dose (2.4 mg weekly) achieved an average weight reduction of 14.9% of their baseline body weight compared to 2.4% in the placebo group. This translates to approximately 15-17 kg (33-37 pounds) for individuals starting at 100 kg, though results ranged from minimal loss to over 30% reductions in some cases.
Weight loss typically follows a dose-escalation pattern, with more noticeable results appearing as your body adjusts and your dose reaches therapeutic levels. Most participants experience gradual, consistent loss rather than rapid drops, which supports better metabolic adaptation and long-term success. The plateauing of weight loss after 6-12 months is normal and reflects the medication's satiety mechanism working optimally rather than a treatment failure.
Individual Factors That Influence Your Personal Weight Loss Potential
Your genetic makeup plays a significant role in how your body responds to semaglutide and other GLP-1 compounds. Variations in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and metabolic pathways like FTO (rs9939609) can predict whether you're a strong responder or may require alternative strategies. PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and 150+ genetic insights to reveal how your body's appetite and energy systems interact with semaglutide specifically.
Starting body weight, age, baseline metabolic rate, and insulin resistance all influence the magnitude of weight loss you'll achieve. Someone with a higher initial weight and insulin resistance may lose more total pounds but a similar percentage of body weight compared to someone with lower starting weight. Diet quality, consistent exercise, sleep duration, and stress management amplify medication effects—semaglutide works best when paired with sustainable habits rather than as a standalone intervention.
How PlexusDx Semaglutide Pricing Supports Long-Term Treatment Success
PlexusDx provides compounded semaglutide injections from licensed 503A pharmacies at $149 per month, with three commitment tiers available to fit different budgets and treatment timelines. Your dose may need to go up as your body adapts, but your price won't—meaning you gain access to higher therapeutic doses without escalating costs. This flat-rate model removes financial barriers to reaching your optimal dose, which is critical because underdosing is a common reason people abandon treatment prematurely.
No insurance requirement, no membership fees, and HSA/FSA eligibility make semaglutide accessible regardless of your coverage situation. PlexusDx serves all 50 states, ensuring that geographic location doesn't prevent you from starting treatment. For those interested in optimizing their response further, the Precision Peptide Genetic Test ($99 add-on after first month) identifies which peptide pathways drive your weight loss potential, helping your practitioner fine-tune your protocol.
Timeline Expectations: When to Expect Noticeable Weight Loss Results
Most people notice appetite suppression within the first week or two of starting semaglutide, with measurable weight loss appearing by weeks 3-4 as you naturally consume fewer calories. The first month typically yields 2-4 pounds of loss, with acceleration occurring during weeks 5-12 as your dose reaches therapeutic levels. This early momentum builds motivation and reinforces behavioral changes, creating a positive feedback loop that supports long-term adherence.
Peak weight loss usually occurs between weeks 16 and 52, with a plateau phase beginning around month 6-12 as your body establishes a new metabolic set point. This is not failure—it reflects the medication working as designed by normalizing hunger signals and energy expenditure. Continued adherence maintains your weight loss, while discontinuation typically results in gradual weight regain as appetite hormones normalize. Realistic expectations for sustained weight loss are 10-20% of starting body weight, with some individuals achieving higher reductions through combined genetic predisposition and lifestyle optimization.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight do most people lose in the first month of semaglutide?
Most people lose 2-4 pounds in the first month as appetite suppression begins and caloric intake naturally decreases. Full weight loss acceleration occurs during months 2-3 as your dose escalates to therapeutic levels, so month one is typically when you establish adherence patterns rather than see dramatic results.
Is 10-15% body weight loss realistic, or do some people lose more?
Clinical trials show that 10-15% is the average range, but approximately 30-35% of participants achieve reductions above 15%, with some reaching 20-25% or higher. Your genetic predisposition, starting weight, lifestyle adherence, and individual GLP-1 receptor sensitivity all influence whether you land in the average range or exceed it.
Can I lose weight faster by increasing my semaglutide dose quickly?
No—rapid dose escalation increases nausea and side effects without accelerating weight loss meaningfully. The standard 4-week dose escalation protocol is designed to maximize tolerance and sustainable results. PlexusDx compounded semaglutide allows your provider to customize your escalation timeline based on your response and tolerability.
What happens to weight loss if I stop taking semaglutide?
Weight regain typically begins within weeks of discontinuation as appetite hormones normalize and caloric intake increases. On average, people regain 50% of lost weight within a year of stopping, though lifestyle habits maintained during treatment can slow this process. Long-term weight management usually requires ongoing or periodic treatment.
How does the Precision Peptide Genetic Test help predict my weight loss potential?
PlexusDx's genetic test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 other metabolic pathways to reveal your individual response profile. This $99 add-on identifies whether you're likely a strong responder to semaglutide, whether dual-compound therapy might benefit you more, and which lifestyle factors matter most for your genetics—transforming generic expectations into personalized predictions.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Mastering Your Semaglutide Shot: Optimal Timing for Weight Loss and Well-being
How Fast Does Ozempic Make You Lose Weight?